Stichting TRICALS

Homepage: tricals.org

Alternate names: TRICALS Foundation, Treatment Research Initiative to Cure ALS

ROR: 00yv39d15

OpenAlex ID: I4405267047

PRECISION ALS—an integrated pan European patient data platform for ALS

2023 · Robert McFarlane, Miriam Galvin, et al. · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · 30

TDP-43 Vasculopathy in the Spinal Cord in Sporadic Amyotrophic Lateral Sclerosis (sALS) and Frontal Cortex in sALS/FTLD-TDP

2021 · Isidro Ferrer, Pol Andrés-Benito, et al. · Journal of Neuropathology & Experimental Neurology · 29

Lipid alterations in human frontal cortex in ALS‐FTLD‐TDP43 proteinopathy spectrum are partly related to peroxisome impairment

2020 · Pol Andrés‐Benito, Ellen Gelpi, et al. · Neuropathology and Applied Neurobiology · 27

Lithium carbonate in amyotrophic lateral sclerosis patients homozygous for the C-allele at SNP rs12608932 in UNC13A: protocol for a confirmatory, randomized, group-sequential, event-driven, double-blind, placebo-controlled trial

2022 · Sean W. Willemse, Kit C. B. Roes, et al. · Trials · 20

A phase 4, randomized, double-blind, placebo-controlled trial evaluating the efficacy and tolerability of rimegepant for the prevention of episodic migraine in adults with a history of inadequate response to traditional oral preventive medications

2025 · Patricia Pozo-Rosich, José Antonio Gien López, et al. · Cephalalgia · 9

Speech-based digital endpoints track ALS progression and align with standard clinical outcomes: evidence from the VRG50635 trial

2026 · Michael Neumann, Hardik Kothare, et al. · Scientific Reports · 5

Challenges and solutions to complex data governance issues in cross-national, cross-sectoral, multidisciplinary real world health research: a descriptive overview

2025 · Miriam Galvin, Mark Heverin, et al. · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · 3

Sensitivity of Digital Clinical Biomarker Endpoints to Detect Disease Progression during the 8-week Pretreatment Run-In Period in Proof-of-Concept ALS Study VGCS-50635-002 (S27.003)

2025 · Diego Cadavid, Dina Katabi, et al. · Neurology · 1

International network for ALS research and care (INARC)

2024 · Juliette Foucher, Tommy M. Bunte, et al. · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · 1

Rimegepant for the Prevention of Episodic Migraine in Adults with Prior Inadequate Response to Oral Preventatives: Results from a 12-week Open-label Extension Phase of a Randomized, Placebo-controlled Trial (P10-15.011)

2026 · Patricia Pozo-Rosich, Jose Gien-Lopez, et al. · Neurology

Clinical drug development in amyotrophic lateral sclerosis: industry-reported challenges and opportunities

2026 · Famke S. Cosijn, Jordi W.J. van Unnik, et al. · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration

Works count: 11

Citation count: 211